SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for ProKidney Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-22 3:32 pm Purchase | 2024-08-28 | 13G | ProKidney Corp. PROK | SUVRETTA CAPITAL MANAGEMENT LLC | 13,198,766 10.470% | 8,473,418 (+179.32%) | Filing |
| 2024-02-13 5:27 pm Sale | 2023-12-31 | 13G | ProKidney Corp. PROK | SUVRETTA CAPITAL MANAGEMENT LLC | 4,725,348 7.000% | -1,554,827 (-24.76%) | Filing |
| 2023-02-13 4:37 pm Purchase | 2022-12-31 | 13G | ProKidney Corp. PROK | SUVRETTA CAPITAL MANAGEMENT LLC | 6,280,175 10.200% | 10,875 (+0.17%) | Filing |
| 2022-07-21 5:44 pm Purchase | 2022-07-11 | 13G | ProKidney Corp. PROK | SUVRETTA CAPITAL MANAGEMENT LLC | 6,269,300 10.200% | 6,269,300 (New Position) | Filing |